NCT00003479View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Patients With Ependymoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 1966

Primary Completion Date

October 31, 2000

Study Completion Date

October 31, 2000

Conditions
Ependymoma
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Patients with an ependymoma will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER